I just
finished some junk bond research and found one that looks very interesting.
Lantheus Medical Imaging 9.75% of 05/15/2017. This bond has 4 years and 7
months until maturity. So the “Yield to Maturity” is approx. 12.215%. This means that inflation is probably not a threat
for the life of the bond. This bond is
rated Caa2 by Moody’s and B by S&P. This bond is not on bond watch. According
to these ratings, the bond will not be going into default anytime soon. But
nothing is guaranteed. The debt ranking is “Senior Unsecured.” The resent price
of the bond was $930 giving $97.50 per year in
interest. It pays every May 15th and Nov 15th until
maturity. It pays $1,000 on May 15,
2017.
To find the
bond in your bond store use this CUSIP No. 516545AC4. People who took my bond free
online course know what I am talking about.
Who cares
what Congress and the President does with this budget crap. We all know that
sooner or later the national bills have to be paid. All the politicians are
going to do in the end is declare victory for their side and go home. So we
really do not have to care about that. If the bond holder is not paid, the
company goes into chapter 11 bankruptcy.
What do they do?
LANTHEUS MEDICAL IMAGING,
a global leader in developing, manufacturing and distributing innovative
diagnostic imaging agents, is dedicated to creating and providing pioneering
medical imaging solutions to improve the treatment of human disease.
Their proven success in discovering, developing,
and commercializing innovative medical imaging agents provides a strong
platform from which to bring forward breakthrough new tools for the diagnosis
and management of disease. LANTHEUS has a rich heritage and expertise in
cardiovascular imaging and nuclear medicine, having pioneered many of the most
significant products used in medical imaging.
Our current imaging agents primarily assist in
the diagnosis of heart, vascular and other diseases using nuclear imaging,
echocardiography and magnetic resonance imaging (MRI) technologies. We also
have a full clinical and preclinical development pipeline of next-generation
and first-in-class products using Positron Emission Tomography (PET) and MRI
technologies.
Our vision is to be the leading provider of
innovative medical imaging solutions to improve human life. We are committed to
developing next generation and first-in-class imaging agents to assist
physicians in the diagnosis of heart, vascular and other diseases.
With direct operations in the United States,
Puerto Rico, Canada and Australia, we have a long and distinguished history of
developing and commercializing innovative market-changing products.
This company sounds like that it will benefit
from the full implementation of Obamacare!
What do the employees think?
Being an investor is one thing. Working for Lantheus Medical
Imaging is another. This is a comment written in the Blog, “Glass Door” by one
of the company’s employees, “Leadership of the company is a joke. The goal of
the company is to manipulate the bottom line to make it attractive to
perspective buyers. This has mostly been accomplished by layoffs. At least 33%
of employees have been laid off in the four years since Lantheus has acquired
the business...and the layoffs continue. Long time employees were once very
supportive of one another but now it is every man (woman & child) for
themselves. Senior Management has created a toxic and stressful environment
where everyone is fearful of losing their jobs. Salaried employees are expected
to work at least 50 hours a week at the site. Hourly employees have had their
work schedules staggered to accommodate odd work schedules without the company
having to pay them overtime.”
“Advice to Senior Management – The Company is being run out of sheer
greed with minimal regard for the well-being of its employees. It unfortunately
represents all too much of a microcosm of the worst of what is happening in the
business world today.”
Investor Relations
- Phone: 978-671-8001
- Email Address: ir@lantheus.com
No comments:
Post a Comment